Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma
News
Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as ... Read more